Related Experiment Video
Updated: Sep 17, 2025
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Leuprorelin-Induced Thrombocytopenia Successfully Treated With Surgical Resection of the Injection Site
Ryota Mori1, Satoru Taguchi1, Masahiro Yamamoto1
1Department of Urology, Graduate School of Medicine The University of Tokyo Tokyo Japan.
Introduction:
Drug-induced thrombocytopenia (DITP) can be caused by many kinds of drugs. Its treatment generally involves discontinuation of the responsible drug.
Case Presentation:
A 70-year-old man received a subcutaneous injection of long-acting (24-week) leuprorelin depot as androgen deprivation therapy for prostate cancer. Four days after the injection, he presented with gingival bleeding and his platelet count was remarkably decreased (< 1000/μL). There was no sign of malignancy but the presence of megakaryocytes on bone-marrow examinations. Considering immune and/or DITP, he started immunoglobulin and steroid therapy while stopping all suspected medications. However, even a month later, his platelet count did not recover with the need for frequent platelet transfusions. Therefore, he eventually underwent surgical resection of the leuprorelin injection site. After the surgery, his platelet count drastically recovered and platelet transfusion became unnecessary.
Conclusion:
We report a case of leuprorelin-induced thrombocytopenia that was successfully treated with surgical resection of the injection site.
